Acquired Resistance to Decitabine Associated with the Deoxycytidine Kinase A180P Mutation: Implications for the Order of Hypomethylating Agents in Myeloid Malignancies Treatment.

与脱氧胞苷激酶 A180P 突变相关的地西他滨获得性耐药：对髓系恶性肿瘤治疗中低甲基化药物顺序的影响